By Steven ReinbergHealthDay Reporter
FRIDAY,March 11, 2016 (HealthDay News) — A unusual genetic test seems to accurately identify women with early stage breast cancer who don’t need chemotherapy, or German researchers report.
The test is called the 21-gene recurrence score (Oncotype DX). Among women that the test indicated didn’t need chemotherapy,94 percent were alive and [...]
Source: health.com